Clinical trial · Observational
Developing and Validating Fertilit-e
Developing and Validating Fertilit-e: An eHealth Fertility Preservation Decision Aid for Young Adults With Cancer - Aim 1
NCT03599661CI-TRIAL-00084504terminatedResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): PI decision - competing study
Summary
Brief summary (as posted)
The main purpose of this project is to adapt and validate an eHealth fertility preservation decision-making support tool (Fertilit-e) for young adults with cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignant Neoplasm | Malignant Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Interview | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Fertilit-e
- description
- Participants review Fertilit-e content, undergo interviews about issues of content, functionality, and ease of use, and complete questionnaires over 45-60 minutes.
- interventionNames
- Other: Interview
- Other: Questionnaire Administration
Primary outcomes (2)
- measure
- Evaluation of Fertilit-e Alpha - Usability (Number of Participants)
- timeFrame
- 6 months
- description
- To evaluate Fertilit-e alpha, we will examine its usability through a series of think aloud interviews. Qualitative analysis will provide an integrative summary and identification of key points, potential themes, and areas of further exploration.
- measure
- Evaluation of Fertilit-e Alpha- Usability (System Usability Scale)
- timeFrame
- 6 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 39 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically confirmed diagnosis of cancer during ages 15 to 39. * Will be receiving or have received treatment associated with a risk of infertility (i.e., systemic chemotherapy, pelvic radiotherapy, and/or pelvic surgery with potential impact on reproductive function). * Considered or wish they had considered fertility preservation treatments. * Able to speak, read, and understand English. * Able to provide informed consent. * Have internet access. * Have a laptop or desktop computer that can connect to WebEx. Exclusion Criteria: * Infertility diagnosis prior to cancer diagnosis. * History of fertility preservation or fertility treatments prior to their cancer diagnosis. * Are more than five years post-cancer-related treatments (i.e., systemic chemotherapy, pelvic radiotherapy, and/or pelvic surgery).
References
Publications (0)
Data not yet available
No reference posted for this study.